Barclays’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-3,976
| Closed | -$73K | – | 4025 |
|
|
2020
Q4 | $73K | Sell |
3,976
-1,716
| -30% | -$31.5K | ﹤0.01% | 3068 |
|
|
2020
Q3 | $104K | Buy |
+5,692
| New | +$104K | ﹤0.01% | 3023 |
|
|
2020
Q1 | – | Sell |
-6
| Closed | – | – | 4063 |
|
|
2019
Q4 | $0 | Sell |
6
-5,961
| -100% | – | ﹤0.01% | 4437 |
|
|
2019
Q3 | $89K | Sell |
5,967
-1,832
| -23% | -$27.3K | ﹤0.01% | 3462 |
|
|
2019
Q2 | $129K | Buy |
7,799
+4,445
| +133% | +$73.5K | ﹤0.01% | 3453 |
|
|
2019
Q1 | $58K | Buy |
+3,354
| New | +$58K | ﹤0.01% | 3586 |
|
|
2018
Q4 | – | Sell |
-4,348
| Closed | -$79K | – | 4571 |
|
|
2018
Q3 | $79K | Buy |
4,348
+3,497
| +411% | +$63.5K | ﹤0.01% | 3551 |
|
|
2018
Q2 | $16K | Sell |
851
-749
| -47% | -$14.1K | ﹤0.01% | 3740 |
|
|
2018
Q1 | $28K | Sell |
1,600
-600
| -27% | -$10.5K | ﹤0.01% | 3753 |
|
|
2017
Q4 | $25K | Buy |
+2,200
| New | +$25K | ﹤0.01% | 3635 |
|
|
2017
Q3 | – | Sell |
-9,651
| Closed | -$84K | – | 4206 |
|
|
2017
Q2 | $84K | Buy |
9,651
+9,595
| +17,134% | +$83.5K | ﹤0.01% | 2841 |
|
|
2017
Q1 | $0 | Sell |
56
-89
| -61% | – | ﹤0.01% | 4224 |
|
|
2016
Q4 | $2K | Sell |
145
-6
| -4% | -$83 | ﹤0.01% | 3654 |
|
|
2016
Q3 | $2K | Buy |
+151
| New | +$2K | ﹤0.01% | 3660 |
|
|
2015
Q4 | – | Sell |
-51
| Closed | -$1K | – | 3940 |
|
|
2015
Q3 | $1K | Sell |
51
-137
| -73% | -$2.69K | ﹤0.01% | 3821 |
|
|
2015
Q2 | $7K | Buy |
+188
| New | +$7K | ﹤0.01% | 3477 |
|